TA 53 – First-Generation Smallpox Vaccine Potency Testing
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit: Inquire with Unit
Memorial Deadline: Monday 9th, December 2019
External Deadline: Thursday 12th, December 2019
Description
CIMVHR, in collaboration with the project sponsor, is operationalizing a number of funding opportunities. The following is a list of current funding opportunities:
- to design, develop and qualify an in-vitro cell based plaque assay to assess the potency of the first-generation smallpox vaccine expressed in terms of plaque forming units per millilitre (PFU/mL).
Attachments
Note: All proposals must be submitted through the online call for proposal portal (https://funding.cimvhr.ca/login) and contain the required information as noted on the Request for Proposal document. Proposals received outside of the portal or that do not contain the necessary required information will not be considered.
For further information, please contact the following individual(s).
Heather MacArthur
Projects and Contracts Specialist
Tel: 613-533-6000 x 79098 E: heather.macarthur@queensu.ca
Jocelyne Halladay
Contracts and Publications Coordinator
Tel: 613-533-6000 x 74756 E: jocelyne.halladay@queensu.ca